Breast Neoplasms: all 12,820 studies
Page 102 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast CancerCompletedNCT01712893Phase 3
- PET/CT in Evaluating Response to Chemotherapy in Patients With Breast CancerTerminatedNCT01712815Not applicable
- Clinical Trial to Evaluate the Safety and Efficacy of Breast ImplantStatus unknownNCT01711710Not applicable
- Epidemiology and Management of Metastatic Breast CancerCompletedNCT01711502
- Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast CancersStatus unknownNCT01710605Phase 3
- Letrozole and CDK 4/6 Inhibitor for ER Positive, HER2 Negative Breast Cancer in Postmenopausal WomenStatus unknownNCT01709370Phase 2
- Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast CancerTerminatedNCT01708798Phase 2/3
- The Impact of Physical Activity on the Outcome of SurgeryCompletedNCT01707121
- Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT01706432
- Local Treatment by Thermic Destruction of Primitive Breast CancerCompletedNCT01706016Phase 2
- Evaluation of Attitudes About FertilityStatus unknownNCT01705561
- Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryTerminatedNCT01705340Phase 1
- Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021).CompletedNCT01703520
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy IndexCompletedNCT01701050
- Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast CancerCompletedNCT01698658Not applicable
- Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast CancerTerminatedNCT01698281Phase 2
- PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerTerminatedNCT01697293Phase 1/2
- Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast CancerCompletedNCT01695226Phase 2
- Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast CancerWithdrawnNCT01695057Not applicable
- Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer SurvivorsCompletedNCT01694225Not applicable
- Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With TaxanesCompletedNCT01693549Phase 2
- The Effect of Dexmedetomidine of the Immune SystemCompletedNCT01692210
- Study of Nab-Paclitaxel in High Risk Early Breast CancerCompletedNCT01690702Phase 3
- Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)TerminatedNCT01690325Phase 2
- Non-interventional Study With Nab-Paclitaxel (Abraxane®)CompletedNCT01689610
- Trial Comparing Calendula Officinalis With Aqueous Cream "Essex" to Treat Skin Reactions From Radiotherapy of Breast CancerCompletedNCT01688479Phase 3
- Single Fraction Intraoperative RadiotherapyCompletedNCT01688388Not applicable
- Iyengar Yoga for Chemotherapy-induced Fatigue in Breast Cancer PatientsWithdrawnNCT01686737Not applicable
- Exercising Our ABC's (African- American Breast Cancer Survivors)CompletedNCT01684579Early Phase 1
- GRN1005 for Brain Metastases From Breast or Lung CancerWithdrawnNCT01679743Phase 2
- An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast CancerCompletedNCT01677455Phase 2
- Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast CancerCompletedNCT01676753Phase 1
- The Effectiveness of Mindfulness on Chronic Pain in Breast Cancer SurvivorsCompletedNCT01674881Not applicable
- Cisplatin + RT for Triple Negative Breast CancerCompletedNCT01674842Phase 1
- Phase I: At-Home Support for Rural Women Using Group Video CallingCompletedNCT01672684Phase 1
- BRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based ChemotherapyCompletedNCT01672671Phase 2
- Effect of Upper Limb Posture on Limb Volume as Expressed in Circumference Measurement in Healthy Women and in Women With Breast Cancer Related LymphedemaStatus unknownNCT01672125
- Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer PatientsCompletedNCT01672021Not applicable
- Cryotherapy for Breast Cancer TrialCompletedNCT01671943Not applicable
- Sentinel Lymph Node Total Tumoral Load as a Predictor of Non Sentinel Node Involvement in Early Breast CancerCompletedNCT01669265
- Pharmacogenomic Study of Neoadjuvant Eribulin for HER2 Non-overexpressing Breast CancerCompletedNCT01669252Phase 2
- Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast CancerCompletedNCT01669239Phase 2
- The Effects of Pre-operative Physical Therapy EducationWithdrawnNCT01669187Not applicable
- Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -PositiveCompletedNCT01668914Phase 3
- Detection of Benign and Malignant Thyroid and Breast Tumors by Fourier Transform Infrared SpectrometryStatus unknownNCT01668238
- Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32Status unknownNCT01666171
- Technology and Navigation to Improve Survivorship CareStatus unknownNCT01663870
- A Study to Assess the Ability of a Novel Endocrine Treatment for Breast Cancer, Irosustat, to Slow Down Cancer GrowthTerminatedNCT01662726Phase 2
- Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast CancerStatus unknownNCT01662128Phase 2/3
- Breast Cancer and Quality of LifeCompletedNCT01661816
- An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01661153
- The Ghana Breast Health StudyCompletedNCT01661023
- BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and HematologyCompletedNCT01660776
- An Open-label, Multi-center Phase Ⅳ Trial to Evaluate the Efficacy and Safety of Sequential Neoadjuvant Chemotherapy With Docetaxel(Monotaxel®) After Doxorubicin Plus Cyclophosphamide Combination Chemotherapy in Locally Advanced Breast CancerCompletedNCT01660542Phase 4
- Multi-peptide Vaccine With Basilixumab for Breast CancerCompletedNCT01660529Early Phase 1
- Phase II Study of Docetaxel +/- Nintedanib in Breast CancerCompletedNCT01658462Phase 2
- ErbB2 Positive Metastatic Breast CancerTerminatedNCT01658358Phase 1/2
- Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast CancerWithdrawnNCT01658176Phase 2
- Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) PatientsCompletedNCT01658033Phase 2
- A Study of Reolysin For Patients With Advanced/Metastatic Breast CancerCompletedNCT01656538Phase 2
- A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)TerminatedNCT01655992Phase 3
- Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PDStatus unknownNCT01655004Not applicable
- Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast CancerStatus unknownNCT01654367Phase 2/3
- Dimethyldiguanide Combined With Aromatase Inhibitor (AI) in Metastatic Breast CancerCompletedNCT01654185Phase 2
- A Study of Famitinib Malate in HER2-negative Metastatic Breast CancerCompletedNCT01653574Phase 2
- A Study of Apatinib in Non-triple-negative Metastatic Breast CancerCompletedNCT01653561Phase 2
- Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic PathwayTerminatedNCT01653366Not applicable
- Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant ChemotherapyStatus unknownNCT01652560
- Study of Erlotinib and Metformin in Triple Negative Breast CancerCompletedNCT01650506Phase 1
- Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing ChemotherapyTerminatedNCT01649258Phase 1
- Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast CancerStatus unknownNCT01648608Phase 2/3
- Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast CancerStatus unknownNCT01647672Phase 2/3
- Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast CancerCompletedNCT01647607Not applicable
- Pilot Study for Young Women's InterventionCompletedNCT01647594Not applicable
- High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast CancerActive, not recruitingNCT01646034Phase 3
- Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast CancerCompletedNCT01645839Phase 3
- The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast CancerCompletedNCT01643148
- Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast CancerStatus unknownNCT01642771Phase 3
- Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -NegativeCompletedNCT01642511Phase 2
- Diagnosis and Prediction of Taxanes Induced Cardiac DysfunctionCompletedNCT01641562
- "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer"Status unknownNCT01641406Phase 2
- Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive SymptomsCompletedNCT01641068Not applicable
- Isolation and Characterization of Cancer Stem Cells Using iFP TechniqueStatus unknownNCT01641003
- MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone MetastasesWithdrawnNCT01640847Phase 2
- Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsCompletedNCT01639911Phase 1
- Pilot Functional Imaging Study to Evaluate Mechanisms Underlying Chronic Pain in Breast Cancer PatientsCompletedNCT01639417
- Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBCCompletedNCT01639248Phase 2
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer PatientsCompletedNCT01638247Phase 3
- Vinorelbine Plus Capecitabine Versus Docetaxel Plus Capecitabine in Anthracycline-pretreated Women With Metastatic Breast CancerStatus unknownNCT01635465
- The Diagnostic Technology Applied Research of CDK5RAP2 in Breast CancerStatus unknownNCT01634984
- Developing Culturally-Tailored Information-Based Support Groups for Chinese Immigrants With Breast CancerWithdrawnNCT01632956
- Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast CancerCompletedNCT01632332Phase 1
- My Lifestyle Intervention of Food and ExerciseCompletedNCT01630499Not applicable
- Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in PolandStatus unknownNCT01630226Phase 2
- Feasibility of a Supportive Education Program for Latina Breast Cancer SurvivorsTerminatedNCT01628887Not applicable
- Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast CancerCompletedNCT01627704Not applicable
- Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer SurvivorsCompletedNCT01627366Not applicable
- Living Conditions and Breast CancerCompletedNCT01626950
- A Randomized, Open-label Phase III Trial of Mapisal® Versus an Urea Hand-foot Cream as Prophylaxis for Capecitabine-induced Hand-foot Syndrome in Patients With Gastrointestinal Tumors or Breast CancerNo longer availableNCT01626781